A Dose‐Tailored Anti‐Plasma Cell Regimen Lowers the Mortality of Late‐Stage Cardiac Amyloidosis

A Dose‐Tailored Anti‐Plasma Cell Regimen Lowers the Mortality of Late‐Stage Cardiac Amyloidosis

ABSTRACT A major obstacle to using current guideline‐recommended chemotherapy in patients with advanced light‐chain cardiac amyloidosis (LCCA) is their intolerance to standard drug dosages. The study aimed to assess the efficacy and safety of the dose‐tailored BD and DBD regimen proposed by our team...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yun Ti, Huaitao Yu, Ying Wang, Mei Ni, Tongtao Liu, Luqun Wang, Cheng Zhang, Peili Bu, Yun Zhang
Format:	Article
Language:	English
Published:	Wiley 2025-07-01
Series:	MedComm
Subjects:	cardiac amyloidosis cardiac response dose‐tailored anti‐plasma cell regimen heart failure hematologic response
Online Access:	https://doi.org/10.1002/mco2.70219
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case Report: A missed diagnosis of cardiac amyloidosis using echocardiography due to immunoglobulin light chain amyloidosis with normal wall thickness in the early stage
by: Xiaohui Li, et al.
Published: (2024-12-01)

Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis
by: Alessia Argirò, et al.
Published: (2025-04-01)

Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies
by: Dana Emilia Movila, et al.
Published: (2025-05-01)

A propensity-matched analysis of cardiac operation in patients with and without cardiac amyloidosisCentral MessagePerspective
by: Akshay Chauhan, MBBS, et al.
Published: (2024-12-01)

Future Directions in Cardiac Amyloidosis
by: Barry Trachtenberg
Published: (2022-03-01)

Systemic Amyloidosis with Cardiac Involvement: Features of Course and Diagnostic Difficulties
by: E. V. Voloshinova, et al.
Published: (2024-08-01)

Delays in diagnosis and treatment of ATTR cardiac amyloidosis: A real‐world data analysis
by: Julia Vogel, et al.
Published: (2025-08-01)

Early identification of cardiac ATTR amyloidosis: a clinical case
by: A. A. Vedernikov, et al.
Published: (2024-07-01)

Role of endogenous T1ρ and its dispersion imaging in differential diagnosis of cardiac amyloidosis
by: Keyan Wang, et al.
Published: (2024-01-01)

First case of cardiac amyloidosis presenting as right atrial mass
by: Aynur Acibuca, et al.
Published: (2019-08-01)

Phenotypic Presentation and Longitudinal Characterization of Hereditary ATTRv Amyloidosis in Previously Undiagnosed Family Members
by: Luca Fazzini, MD, et al.
Published: (2025-08-01)

Maintenance therapy promotes profound organ and haematologic response in light-chain amyloidosis patients not undergoing autologous stem cell transplantation
by: Wenjing Wang, et al.
Published: (2024-12-01)

Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis
by: Jennifer M. Amadio, et al.
Published: (2025-02-01)

Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery
by: Joanna Waś, et al.
Published: (2025-07-01)

Unraveling gut microbiome alterations and metabolic signatures in hereditary transthyretin amyloidosis
by: Hanyu Li, et al.
Published: (2025-07-01)

Navigating the Diagnostic and Management Challenges of Suspected Cardiac Amyloidosis in Resource‐Limited Settings: Ethiopia Experience
by: Sura Markos, et al.
Published: (2024-11-01)

Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
by: Kelty R. Baker
Published: (2022-03-01)

From the Bone Marrow to the Heart
by: Dia A. Smiley, DO, et al.
Published: (2025-01-01)

Integrated specialty care for amyloidosis: a scoping review using the Consolidated Framework for Implementation Research
by: Mary O’Sullivan, et al.
Published: (2025-03-01)

Bone scintigraphy imaging of cardiac amyloidosis
by: Issa Menge Kuria, et al.
Published: (2019-07-01)

SYSTEMIC AMYLOIDOSIS PRESENTING WITH LYMPHADENOPATHY: A DIAGNOSTIC OVERLAP WITH MULTIPLE MYELOMA AND POSSIBLE CARDIAC INVOLVEMENT
by: Naciye Nur Tozluklu, et al.
Published: (2024-12-01)

Echocardiographic Tissue Characterization Using Radiomics in Patients With Transthyretin-Related Cardiac Amyloidosis
by: Sara Mori, MD, et al.
Published: (2025-06-01)

It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis
by: Jean Michel Saad, et al.
Published: (2022-03-01)

Cardiac Amyloidosis Treatment
by: Lily K. Stern, et al.
Published: (2022-03-01)

Case Report: Avoiding misdiagnosis in amyloidosis—navigating transthyretin genopositivity and monoclonal gammopathy in a patient with advanced heart failure and spinal stenosis
by: Xia Wu, et al.
Published: (2024-12-01)

Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review
by: Martha Grogan, et al.
Published: (2025-04-01)

Prevalence of Atrial Fibrillation and Intervention Therapy in Cardiac Amyloidosis
by: Runzhe Wu, et al.
Published: (2025-05-01)

Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real‐World Data
by: Maximilian Leo Müller, et al.
Published: (2024-07-01)

Diagnostic pathway for cardiac amyloidosis from the healthcare professional’s perspective: results from the French DIAM-ATTR survey
by: Silvia Oghina, et al.
Published: (2025-12-01)

Diagnostic value of bone scintigraphy versus cardiovascular magnetic resonance in cardiac amyloidosis
by: Josefin Obergassel, et al.
Published: (2025-01-01)

Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience
by: Khush Patel, MD, et al.
Published: (2025-08-01)

A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01)

Double Delayed Enhancement: Concomitant Cardiac Amyloidosis and Acute Coronary Embolism
by: Talha Ahmed, et al.
Published: (2021-08-01)

Prevalence and prognostic value of different iron deficiency definitions in light chain cardiac amyloidosis patients
by: Xinqing Li, et al.
Published: (2025-06-01)

Evaluating the Role of Multimodal Imaging in the Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
by: Zi‐xin Yang, et al.
Published: (2025-05-01)

Novel Insights into Non-Invasive Diagnostic Techniques for Cardiac Amyloidosis: A Critical Review
by: Marco Maria Dicorato, et al.
Published: (2024-10-01)

Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis
by: Martha Grogan, et al.
Published: (2025-09-01)

Novel three‐dimensional ECG algorithm for reliable screening for cardiac amyloidosis
by: Amir A. Mahabadi, et al.
Published: (2025-08-01)

Assessing microvascular dysfunction and predicting long-term prognosis in patients with cardiac amyloidosis by cardiovascular magnetic resonance quantitative stress perfusion
by: Leting Tang, et al.
Published: (2025-01-01)

The effect of trimetazidine on cardiac haemodynamics and mitochondrial function in wild‐type transthyretin amyloidosis
by: Bertil Thyrsted Ladefoged, et al.
Published: (2025-06-01)